Showing 18,201 - 18,220 results of 31,824 for search '(( a step decrease ) OR ( 50 ((ng decrease) OR (((nn decrease) OR (a decrease)))) ))', query time: 0.87s Refine Results
  1. 18201

    The kava root extract and kavalactones down-regulate expression of AR and AR target genes (<i>PSA</i> and <i>TMPRSS2</i>) via accelerating the degradation of AR protein. by Xuesen Li (48046)

    Published 2013
    “…The protein expression of AR and PSA in LNCaP and C4-2B cells after indicated treatments at a concentration of their IC<sub>50 s</sub> for 16 hours was analyzed by Western blot. α-Tubulin was detected as a loading control. …”
  2. 18202
  3. 18203

    Gene expression comparison between <i>C. albicans</i> alone and drug-treated groups in <i>Galleria mellonella</i>. by Nadja Rodrigues de Melo (485602)

    Published 2013
    “…On the other hand this treatment also caused a significant decrease of gene expression of IMPI, C5 (*p<0.001), C6 and C7 (**p<0.05). …”
  4. 18204
  5. 18205

    Characterization of Biofilm Formation in <i>[Pasteurella] pneumotropica</i> and <i>[Actinobacillus] muris</i> Isolates of Mouse Origin by Martin Sager (444817)

    Published 2015
    “…Taken together, these findings provide a first step in understanding of the biofilm mechanisms in <i>[P</i>.…”
  6. 18206

    Electrodeposition-Based Janus Membrane for Unidirectional Transportation and Oil–Water Separation by Irfan Majeed Bhat (14671034)

    Published 2025
    “…This study introduces a Janus membrane with opposite wettability characteristics on its two faces fabricated through a dual-step process combining selective electrodeposition and chemical vapor deposition (CVD). …”
  7. 18207

    Electrodeposition-Based Janus Membrane for Unidirectional Transportation and Oil–Water Separation by Irfan Majeed Bhat (14671034)

    Published 2025
    “…This study introduces a Janus membrane with opposite wettability characteristics on its two faces fabricated through a dual-step process combining selective electrodeposition and chemical vapor deposition (CVD). …”
  8. 18208

    Electrodeposition-Based Janus Membrane for Unidirectional Transportation and Oil–Water Separation by Irfan Majeed Bhat (14671034)

    Published 2025
    “…This study introduces a Janus membrane with opposite wettability characteristics on its two faces fabricated through a dual-step process combining selective electrodeposition and chemical vapor deposition (CVD). …”
  9. 18209

    An Atypical Mitochondrial Carrier That Mediates Drug Action in <i>Trypanosoma brucei</i> by Juan P. de Macêdo (735541)

    Published 2015
    “…In addition, down-regulation of TbMCP14 protected bloodstream form mitochondria from a drug-induced decrease in mitochondrial membrane potential. …”
  10. 18210

    Scutellarin’s Cardiovascular Endothelium Protective Mechanism: Important Role of PKG-I<i>α</i> by Lin Li (28817)

    Published 2015
    “…The activation of PKG–1α was then studied using targeted proteomic analysis (MRM-MS) checking the phosphorylation state of the autophosphorylation domain (aa42-94). Significant decrease in phosphorylation of PKG-Iα at Ser50, Ser72, Ser89 was induced by HR injury while SCU treatment significantly increased the phosphorylation of PKG-Iα, not only at Ser50, Ser72 and Ser89, but also at Ser44 and Thr58 (two novel phosphorylation domains). …”
  11. 18211

    Histone deacetylase (HDAC) inhibitor assessment. by Ilona Tkachyova (343715)

    Published 2016
    “…ITF 2357, an HDAC inhibitor which is structurally and functionally similar to SAHA, produced a dose-response curve with IC<sub>50</sub> of 0.2 μM. …”
  12. 18212

    Plk1 inhibition suppresses the clonogenic potential of SUM149 and SUM159. by Antonio Giordano (55096)

    Published 2019
    “…(B) EC<sub>50</sub> was defined as 50% colony inhibition. Single agents EC<sub>50</sub> were reported for each TNBC cell line and drug. …”
  13. 18213

    Image2_Peripheral blood T-cell modulation by omalizumab in chronic urticaria patients.jpeg by Cristina López (2841392)

    Published 2024
    “…</p>Results<p>In patients with CSU under treatment with omalizumab, there was a significant decrease in the percentage of naïve and an increase in the percentage of central memory CD4 T cells as well as a decrease in the percentage of naïve and increase in the percentage of effector CD8 T-cell subsets. …”
  14. 18214

    Image1_Peripheral blood T-cell modulation by omalizumab in chronic urticaria patients.jpeg by Cristina López (2841392)

    Published 2024
    “…</p>Results<p>In patients with CSU under treatment with omalizumab, there was a significant decrease in the percentage of naïve and an increase in the percentage of central memory CD4 T cells as well as a decrease in the percentage of naïve and increase in the percentage of effector CD8 T-cell subsets. …”
  15. 18215

    Table4_Peripheral blood T-cell modulation by omalizumab in chronic urticaria patients.docx by Cristina López (2841392)

    Published 2024
    “…</p>Results<p>In patients with CSU under treatment with omalizumab, there was a significant decrease in the percentage of naïve and an increase in the percentage of central memory CD4 T cells as well as a decrease in the percentage of naïve and increase in the percentage of effector CD8 T-cell subsets. …”
  16. 18216

    Image3_Peripheral blood T-cell modulation by omalizumab in chronic urticaria patients.pdf by Cristina López (2841392)

    Published 2024
    “…</p>Results<p>In patients with CSU under treatment with omalizumab, there was a significant decrease in the percentage of naïve and an increase in the percentage of central memory CD4 T cells as well as a decrease in the percentage of naïve and increase in the percentage of effector CD8 T-cell subsets. …”
  17. 18217

    Table3_Peripheral blood T-cell modulation by omalizumab in chronic urticaria patients.docx by Cristina López (2841392)

    Published 2024
    “…</p>Results<p>In patients with CSU under treatment with omalizumab, there was a significant decrease in the percentage of naïve and an increase in the percentage of central memory CD4 T cells as well as a decrease in the percentage of naïve and increase in the percentage of effector CD8 T-cell subsets. …”
  18. 18218

    Image4_Peripheral blood T-cell modulation by omalizumab in chronic urticaria patients.pdf by Cristina López (2841392)

    Published 2024
    “…</p>Results<p>In patients with CSU under treatment with omalizumab, there was a significant decrease in the percentage of naïve and an increase in the percentage of central memory CD4 T cells as well as a decrease in the percentage of naïve and increase in the percentage of effector CD8 T-cell subsets. …”
  19. 18219

    Table2_Peripheral blood T-cell modulation by omalizumab in chronic urticaria patients.docx by Cristina López (2841392)

    Published 2024
    “…</p>Results<p>In patients with CSU under treatment with omalizumab, there was a significant decrease in the percentage of naïve and an increase in the percentage of central memory CD4 T cells as well as a decrease in the percentage of naïve and increase in the percentage of effector CD8 T-cell subsets. …”
  20. 18220

    Accelerated Optical Projection Tomography Applied to <i>In Vivo</i> Imaging of Zebrafish by Teresa Correia (3956129)

    Published 2015
    “…In this work, we demonstrate that the use of an iterative algorithm to reconstruct sparsely sampled OPT data sets can provide useful 3-D images with 50 or fewer projections, thereby significantly decreasing the minimum acquisition time and light dose while maintaining image quality. …”